Darbepoetin Alfa MDS Companion Protocol

Clinical trial NCT02175277 · COMPLETED

Trial details

NCT number: NCT02175277
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)

Start date: 2014-06-12
Primary completion: 2017-03-20
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.